Avenue Therapeutics’ $5 Million Common Stock Offering

McGuireWoods represented Avenue Therapeutics on the offering, and Ellenoff Grossman & Schole represented Maxim Group LLC.Avenue Therapeutics, Inc. (Nasdaq:ATXI) announced the pricing of its public offering in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here